Back
Armata Pharmaceuticals Vs. Perspective Therapeutics Industry Stock Comparison
Buy
51
ARMP
Armata Pharmaceuticals
Last Price:
$2.22
Seasonality Move:
1.54%
Sell
46
CATX
Perspective Therapeutics
Last Price:
$3.5100
Seasonality Move:
8093.07%
Buy
51
Armata Pharmaceuticals (ARMP)
is a Buy
Is Armata Pharmaceuticals a Buy, Sell or Hold?
-
The current Armata Pharmaceuticals [ARMP] share price is $2.17. The Score for ARMP is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
ARMP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
-
The current Perspective Therapeutics [CATX] share price is $3.5300. The Score for CATX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
CATX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARMP Stock Price Chart
What is Armata Pharmaceuticals's stock price today?
-
The Armata Pharmaceuticals share price today is $2.17Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARMP is experiencing buying pressure, which is a positive indicator for future bullish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $3.5300The current trend is moderately bullish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARMP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 60.28 | Buy |
Chaikin Money Flow: | 10513 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.87 - 2.05) | Buy |
Bollinger Bands (100): | (1.4 - 2.08) | Buy |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.17 | Buy |
Relative Strength Index (14 RSI): | 54.31 | Buy |
Chaikin Money Flow: | 662861 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.094 - 3.734) | Buy |
Bollinger Bands (100): | (2.1404 - 3.2004) | Buy |
ARMP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2 | Buy |
20-day SMA: | 1.96 | Buy |
50-day SMA: | 1.8 | Buy |
200-day SMA: | 1.97 | Buy |
8-day EMA: | 2.03 | Buy |
20-day EMA: | 1.97 | Buy |
50-day EMA: | 1.86 | Buy |
200-day EMA: | 1.99 | Buy |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.52 | Buy |
20-day SMA: | 3.52 | Buy |
50-day SMA: | 2.95 | Buy |
200-day SMA: | 4.99 | Sell |
8-day EMA: | 3.53 | Sell |
20-day EMA: | 3.43 | Buy |
50-day EMA: | 3.11 | Buy |
200-day EMA: | 4.75 | Sell |
Armata Pharmaceuticals Earnings Growth & ARMP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.99 per share, and a decrease next year of $0.00 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.06 per share, a decrease this year of $0.36 per share, and a decrease next year of $0.17 per share.
Armata Pharmaceuticals Technical Analysis
Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |